This article focuses on the procurement side of ANVISA compliance for independent pharmacies in Brazil: specifically, the rules and documentation requirements that apply to how and where you source your medications. It is not a comprehensive compliance guide, and it should not substitute for consulting a farmaceutico responsavel or a compliance advisor who knows your specific situation. What it is is a practical reference for the areas where small pharmacies most commonly encounter compliance gaps related to purchasing.
Operating Authorization: Your AFE and the CRF
Before any procurement-specific requirements, the baseline is that your pharmacy must hold a valid Alvara de Funcionamento (your municipal operating license), have a registered Farmaceutico Responsavel with the CRF (Conselho Regional de Farmacia) in your state, and maintain a valid AFE (Autorizacao de Funcionamento de Empresa) from ANVISA for retail pharmacy operations.
The AFE status matters specifically because it is the identifier that ANVISA uses to track supply chain relationships. When a distributor sells to you and records that transaction, they are recording your AFE as the receiving entity. If your AFE has lapsed, that transaction creates a compliance flag for both you and the distributor.
Check your AFE status on ANVISA's Consulta de Empresas portal at least annually, and whenever you have any change in ownership, physical location, or responsible pharmacist. AFE renewals have deadlines that are easy to miss if you are not tracking them actively.
Supplier Verification: Who You Can Buy From
The rule is straightforward in principle: you may only purchase medications from suppliers who hold a valid ANVISA authorization for distribution or manufacture. In practice, this means you are responsible for confirming the authorization status of every distributor you buy from.
ANVISA maintains a public database of authorized companies. Before opening a commercial relationship with a new distributor, verify their AFE status on this database. This is a five-minute check and it is not optional. "I didn't know they weren't authorized" is not a defense that ANVISA accepts during an inspection.
For distributors you have been working with for years, re-verify periodically. Distributor authorizations can lapse due to regulatory issues, address changes, changes in responsible technical staff, or administrative failures on the distributor's part. A distributor's lapsed authorization becomes your compliance problem the moment you receive a shipment from them.
Receiving Inspection: What to Check When Stock Arrives
When a shipment arrives at your pharmacy from a distributor, the receiving inspection is a compliance step, not just a quality check. The following items should be verified and documented for every incoming shipment:
Product identity: Verify that the products received match the purchase order. Product name, concentration, presentation, and quantity should all be confirmed. Discrepancies need to be documented and resolved with the distributor before the product is accepted into stock.
ANVISA registration number: Every pharmaceutical product sold in Brazil must have a valid ANVISA registration number (numero de registro ANVISA). This appears on the product packaging. For any product where you are not already familiar with the registration, verify it against ANVISA's Bulario Eletronico or equivalent public database. Receiving a product with an invalid or expired registration creates regulatory liability.
Batch number and expiry date: Record both for every incoming shipment. This is required for traceability. If a batch is later subject to a recall, you need to be able to confirm quickly whether you received it and where it went.
Temperature chain documentation: For medications requiring cold chain storage, verify that the delivery documentation includes temperature records for the transit period. Accepting cold chain product without temperature verification records is a gap that ANVISA inspections look for specifically.
Nota fiscal: The nota fiscal from the distributor is the primary document linking your purchase to a specific supplier, product, batch, and date. Keep these organized and retrievable. ANVISA inspectors will ask to see them.
Storage and Traceability Requirements
Once product is accepted into stock, the traceability obligation continues. RDC (Resolucao de Diretoria Colegiada) 44/2009 and subsequent updates from ANVISA establish the requirements for pharmacy operating conditions and record-keeping. The practical procurement-related requirements include:
Separation of product by batch within your storage system. If you receive two shipments of the same product in different batches and mix them on the shelf, you lose the ability to trace which specific batch was dispensed to which patient, which matters in the event of a recall.
First-expiry-first-out (FEFO) stock rotation. This is both a compliance requirement and basic inventory management. Products with earlier expiry dates should be positioned for dispensing first. During an inspection, ANVISA may check shelf organization to confirm FEFO practices.
Controlled substance registers (Livro de Escrituracao) for products subject to SCTM controls. If your pharmacy dispenses controlled psychoactive or narcotic medications, the purchasing and dispensing record-keeping requirements are significantly more detailed. This article does not cover that subsystem in detail; it is worth reviewing RDC 471/2021 and current SCTM requirements with your farmaceutico responsavel.
What "ANVISA-Compliant Procurement" Means for a Platform
When we describe Covalenty as supporting ANVISA-compliant procurement, we mean specifically that every distributor on the platform is required to hold and maintain a valid ANVISA authorization, and that the platform generates the documentation that a pharmacy needs for its own compliance records: the transaction record including supplier identity, products, batch references, and delivery confirmation.
We are not a regulatory enforcement body, and we do not audit distributor compliance beyond initial verification and periodic re-checks. The legal responsibility for verifying your supplier's authorization remains with your pharmacy, as it does regardless of what procurement channel you use. A platform that implies otherwise would be giving you bad advice.
What the platform can do is make the verification step less effort by providing the distributor's authorization details alongside the price quote, and by maintaining records in a format that is easier to retrieve and organize for an inspection than a folder of paper notas fiscais. That is a real operational benefit for a small pharmacy that does not have dedicated administrative staff for compliance record-keeping.
A Note on Inspection Readiness
ANVISA inspections of retail pharmacies in Brazil range from routine scheduled inspections to unannounced visits following complaints or post-market surveillance triggers. The independent pharmacies most likely to receive scrutiny are those that have had prior compliance issues, those in areas where the health surveillance authority (Vigilancia Sanitaria, which operates at the municipal and state level alongside ANVISA) is active, and those dispensing high volumes of controlled substances.
Procurement-related compliance gaps that come up frequently in inspection findings include: missing or incomplete notas fiscais, products received from suppliers whose authorization cannot be verified, absence of batch number records for incoming shipments, and cold chain temperature records that cannot be produced. None of these are difficult to address if you have good systems in place. All of them create real problems if you do not and an inspector asks for them.
The core principle is straightforward even if the implementation takes effort: know who you are buying from, verify they are authorized, document what you received, and keep those records accessible. The specifics can be complex, but the underlying logic is not.
